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Abstract 
Rabbit erythroid cells can take up non-transferrin-bound iron by a high-affinity and a low-affinity transport mechanism (Hodgson et al. 
(1995) J, Cell. Physiol. 162, 181-190). The latter process, which is present in mature erythrocytes as well as reticulocytes, was 
investigated in this study using rabbit reticulocytes and erythrocytes. Iron uptake was optimal in isotonic KCI (pH 7.0), was shown to be 
much greater for Fe(II) than Fe(III), to be saturable with a K m value of approx. 15 /xM Fe(II), temperature-dependent andinhibited by 
inhibitors of cell energy metabolism, by Na + and many divalent cations and by several known inhibitors of membrane cation transport 
mechanisms. Uptake was more rapid with rabbit than with rat or human erythrocytes. The Fe(II) transport process was much more 
sensitive to inhibition by Mg 2+ than by Ca 2+ and the inhibition by both Mg 2+ and Na + was of competitive type. Cells depleted of 
intracellular Mg 2+ by the use of the ionophore A23187 had low rates of Fe(II) uptake. High rates of uptake could be achieved by 
replenishment of intracellular Mg 2+, and the MgZ+-dependent uptake of Fe(II) was inhibited by the same reagents which reduced the 
uptake by untreated cells. Many features of the Fe(II) transport process are very similar to those of the previously described Na +/Mg 2+ 
antiport. These features, plus the stimulation of Fe(II) uptake by intracellular Mg 2+ and inhibition by extracellular Mg 2+ or Na +, 
strongly suggest that the iron is transported into the cells by the antiport. 
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I. Introduction 
The normal mechanism of iron uptake by developing 
red blood cells involves receptor-mediated ndocytosis of 
transferrin [1,2]. However, erythroid cells also possess the 
capacity to take up non-transferrin-bound ferrous iron, 
Fe(II) [3-5]. At least two mechanisms have been described 
to account for the way this form of iron crosses erythroid 
cell membranes [5,6]. These are a high-affinity process 
which is found only in immature cells such as reticulocytes 
and a low-affinity process which is present in mature 
erythrocytes as well as reticulocytes [6]. The high-affinity 
process has been studied in some detail [3,7-9]. It has a 
K m of approx. 0.2 /xM and has the characteristics of 
active transport. It has been proposed that this mechanism 
is the one by which iron released from transferrin within 
endosomes i transferred across the endosomal membrane 
into the cytosol [8,9]. 
Much less information is available on low-affinity iron 
transport. This process was first identified by the stimula- 
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tion of iron uptake which was observed when NaC1 in the 
incubation medium was replaced by KCI [5,6]. It differs 
from the high-affinity mechanism in several ways in addi- 
tion to the affinity for iron. Iron transport becomes more 
prominent as the extracellular i on concentration is raised 
and does not saturate until a level of 40-50 #M is 
reached, compared with 1-2 /zM for high-affinity uptake. 
The capacity to take up iron by the low-affinity pathway 
does not disappear as reticulocytes mature and is unim- 
paired in erythroid cells from homozygous Belgrade rats 
which have an abnormality of iron transport which leads to 
diminished uptake from transferrin or by high-affinity 
Fe(II) transport [6]. Also, low-affinity iron transport is 
inhibited by NaC1 and amiloride, but is stimulated by KC1, 
RbCI, LiC1 and CsC1 [5,6]. These results have led to the 
hypothesis that the iron is transported into the cells by a 
Na+/Fe 2+ counter-transport mechanism [5]. 
The aim of the present work was to investigate the 
mechanism of low-affinity iron transport in erythroid cells. 
Initially, this was undertaken by examining the effects of 
incubation temperature and ATP depletion, of other metal 
ions and of known inhibitors of membrane transport of 
cations. During the course of the work it became apparent 
164 L.M. Stonell et al. / Biochimica et Biophysica Acta 1282 (1996) 163-170 
that extracellular Mg 2+ is an effective inhibitor. Hence, its 
possible role in Fe(II) transport was investigated in some 
detail. The results lead to the conclusion that low-affinity 
Fe(II) transport occurs by the same mechanism as is 
responsible for the exchange of intracellular Mg 2÷ for 
extracellular Na ÷, i.e., by the previously-identified 
Na+/Mg 2+ antiport. 
2. Materials and methods 
2.1. Materials 
Radioactive iron (59 FeCI3) was purchased from Dupont, 
Australia (Sydney, Australia) and the biochemical reagents 
from Sigma Chemical Co. (St. Louis, MO). Reticulocyte- 
rich blood was obtained from rabbits with phenylhydra- 
zine-induced hemolytic anemia, 4-6 days after the last 
injection of phenylhydrazine [10]. Blood with a low reticu- 
locyte count was from normal adult rabbits. The red blood 
cells were washed three times in 0.155 M NaC1 and once 
in 0.155 M KC1 and then suspended in 0.155 M KC1 at a 
packed cell volume (PCV) of approx. 0.30. The cells from 
the anemic rabbits contained 45-70% reticulocytes and, 
from the normal rabbits, 1-3% reticulocytes. They will be 
referred to as reticulocytes and erythrocytes, respectively. 
In one set of experiments erythrocytes were also obtained 
from normal rats and humans by heart puncture and 
venepuncture, respectively, and were washed and sus- 
pended in the same way as the rabbit cells. 
2.2. Measurement of  iron uptake 
In most experiments iron uptake was determined by 
incubating samples of the cell suspensions (usually 80 /.d) 
in 2.0 ml Hepes-buffered (pH 7.0) isotonic KCI solution 
(290 mOsm/kg) at 37°C for 15 min in the presence of 
59Fe-labelled Fe(II) as in earlier work [6]. The cells were 
then washed once with ice-cold 5 mM EDTA in 0.15 M 
NaC1 (pH 7.4) and twice with ice-cold 0.155 M NaCI, 
followed by hemolysis in 15 mM Hepes (pH 7.4) and 
centrifugation to separate cytosolic and stromal fractions 
of the cells [3,6]. These fractions were then counted for 
radioactivity. 
The incubation conditions (KCI, pH 7.0, 15 min) were 
chosen after preliminary studies which showed that the 
rate of iron uptake was maximal in KCI (or RbC1) solution 
at pH 7.0 and that uptake under these conditions was linear 
for at least 30 min. Hence, the 15 rain uptake results 
enable the rate of iron uptake to be calculated. The results 
are expressed as iron uptake in nmol per ml cells for the 
15 min incubation period or as iron uptake per ml cells per 
min, as indicated below. 
The radioactive iron solution was prepared immediately 
before use, by mixing 59Fe (FeC13) with 56Fe (FeSO 4) in a 
molar ratio of approx. 1:100, and diluting to the desired 
concentration with 0.27 M sucrose. An aliquot of this 
solution was then added to the cell incubation mixture to 
give the final iron concentration. I  most experiments his 
was 20 /zM, but in some experiments he concentration 
was varied, as indicated below. By use of the Fe(II) 
colorimetric reagent, a, a'-bipyridine it was shown that the 
iron remained in the ferrous state for the time required for 
the experiments and, due to the rapid self exchange of 
Fe(II) and Fe(III) [11], the iron would be uniformly la- 
belled with 59Fe. 
Changes to the above incubation procedure were made 
in some of the experiments. These include alteration of the 
incubation temperature, or the addition of various mem- 
brane transport inhibitors or the chloride salts of a range of 
cations to the incubation solution. In these cases the cells 
were incubated with the inhibitors or salts for 10 min at 
room temperature before the addition of the 59 Fe-labelled 
Fe(II). Metabolic depletion was achieved by preincubation 
of the cells at 37°C for 30 min in the presence of 5 mM 
iodoacetamide and 5 mM inosine [12]. In some experi- 
ments, the intracellular Mg 2÷ concentration was changed 
before the cells were incubated with 59Fe through the use 
of the ionophore A23187 and solutions containing 0 to 12 
mM MgC12 [13]. In this procedure the A23187 was re- 
moved by four 10 min incubations at 37°C with bovine 
serum albumin (10 mg/ml) in KCI solution (pH 7.0), 
containing the required concentrations of MgC12. 
2.3. Analytical methods 
The reticulocyte count was determined by staining blood 
cells with new methylene blue and the packed cell volume 
by the microhematocrit method. Radioactivity was counted 
in a three-channel y-scintillation counter (LKB 1282 
Compu-Gamma). Osmolality was measured by freezing 
point depression using a Fiske One-Ten Osmometer (Fiske, 
Needham Heights, MA). 
3. Results 
3.1. Uptake of Fe(lI) and Fe(III) 
The ability of reticulocytes and erythrocytes to take up 
Fe(III), as well as Fe(II), was investigated by incubating 
59 the cells with increasing concentrations of Fe-labelled 
Fe(II) prepared as described above, and Fe(III) prepared in 
a comparable way but with the FeSO 4 replaced by FeC13. 
The oxidation state of the iron in the incubation solutions 
was verified by the use of the colorimetric ferrous iron 
chelator, a,a'-bipyridine, which produced a pink col- 
oration immediately after addition to the Fe(II) solution 
but not with the Fe(III) solution. The rate of iron uptake 
from Fe(II) was much greater than from Fe(III) and satu- 
rated as the iron concentration was raised (Fig. 1). At an 
iron concentration of 20 /zM the rate of uptake of Fe(II) 
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Fig. 1. Effect of iron concentration on the uptake of ferrous (0 )  and 
ferric (A) iron to the cytosol of rabbit reticulocytes. The cells were 
incubated for 15 min at 37°C with SgFe-labelled FeSO 4 or FeC13 in 
isotonic KCI (pH 7.0). They were then washed, hemolysed and fraction- 
ated into cytosolic and stromal fractions as described in the text. This 
experiment was repeated 4 other times, with similar results. 
Table 1 
Inhibition of iron uptake by Na + and divalent cations 
ICs0 (/xM) 
Cation Reticulocytes Erythrocytes 
Na + 4300 5:530 4100 ± 290 
Co 2+ 20±5.8 205:2.7 
Ni 2+ 20±4.1 18+ 1.9 
Zn 2 + 19 5:3.6 25:5:3.7 
Mg ~+ 90+ 14 955:6.9 
Mn 2+ 105 5:17 1005:13 
Cd 2+ 1405:15 145 5:21 
Ca 2+ 970 5:112 975 5:125 
Sr 2 + 2500 + 380 2800 5:350 
The uptake of 20 ~M Fe(lI) by reticulocytes and erythrocytes was 
measured using cells which were incubated in isotonic KCI (pH 7.0) 
containing varying concentrations of the chloride salts of Na ÷ or several 
divalent cations. The results are expressed as the concentrations of the 
cations which produced 50% inhibition (IC50) of iron transport into the 
cytosol of the cells. Each value is the mean ( 5: S.E.M.) of three separate 
determinations. 
erythroid cells and led to several of the experiments de- 
scribed below. 
was more than 10 times as great as from Fe(III). Results of 
5 determinations of Fe(II) uptake similar to that shown in 
Fig. 1 were used to calculate the maximal rates (Vma x) and 
Michaelis-Menten constants (K m) for iron uptake. The 
mean values for Vma x were 17.8 + 3.1 and 8.8__+0.8 
nmol/ml cells/min (mean ___ S.E.M.) for reticulocytes and 
erythrocytes, respectively, and the mean K m values were 
14.9 _+ 1.8 and 14.4 _ 2.2 /zM, respectively. It should be 
noted that these values differ somewhat from previous 
results [6]. The reason is that in the earlier experiments he 
incubations were performed at pH 6.5, not 7.0, which has 
since been found to be the optimum pH for the incubation 
conditions used in this study. Lower K m values result 
from the use of the higher pH, indicative of a higher 
affinity of Fe(II) for the iron transporter at pH 7.0 than at 
pH 6.5. 
3.2. Inhibition of iron uptake by NaC1 and divalent cations 
Fe(II) uptake was measured using cells which had been 
preincubated for 10 min at room temperature with the 
chloride salts of several divalent cations. All of the salts 
inhibited iron uptake in a concentration-dependent ma ner. 
At high concentrations they all produced at least 95% 
inhibition. The concentrations of the salts which produced 
50% inhibition of Fe(II) uptake (IC50) varied from 4 mM 
for Na ÷ to 20 /xM for Co 2÷, Ni 2+ and Zn 2+ (Table 1). 
Very similar values were obtained for reticulocytes and 
erythrocytes. When Ca 2÷ and Mg 2÷ were compared, the 
IC50 value for Mg 2÷ was found to be only one-tenth that 
for Ca z+. This raised the question whether there is an 
interaction between the transport of Fe(II) and Mg 2÷ in 
3.3. Effects of cation transport inhibitors on Fe(ll) uptake 
Several reagents which have been shown previously to 
inhibit a variety of cation transport processes were studied 
for their effects on low-affinity Fe(II) transport. Some had 
no effect at the concentrations u ed. These included ouabain 
(500-1000 /zM), bumetanide (10-100 p,M), furosemide 
(30-100 /zM), vanadate (10-1000 p~M) and p-chloro- 
mercuriphenyl-sulfonic acid (10-25 ~M). Others were 
effective inhibitors and their IC50 values are presented in 
Table 2. Iron uptake was particularly susceptible to inhibi- 
tion by valinomycin, oligomycin and diethylstilbestrol, but 
was also blocked by relatively low concentrations of the 
other reagents listed in the table. Once again, the results 
for erythrocytes were very similar to those for reticu- 
Table 2 
Effect of membrane transport inhibitors on iron uptake 
Inhibitor IC50 (/xM) 
Reticulocytes Erythrocytes 
Valinomycin 0.12 ± 0.035 0.093 + 0.017 
Oligomycin 0.34 + 0.024 0.52 ± 0.041 
Diethylstilbestrol 1.1 ± 0.10 1.2 ± 0.10 
Quercetin 6.6 ± 1.0 5.9 ± 1.1 
Imipramine 7.7 ± 0.64 10.0 ± 0.71 
Quinidine 67 + 6.0 100 5:15 
Amiloride 190 ± 17 250 ± 30 
N-Ethylmaleimide 200 ± 6.5 210 5:5.9 
Reticulocytes and erythrocytes were incubated with 20/zM Fe(ll) in KCI 
(pH 7.0) in the presence of varying concentrations of the inhibitors. The 
results show the concentrations of the inhibitors which produced 50% 
inhibition (IC5o) of iron uptake into the cytosol of the cells (means± 
S.E.M. of 3 determinations). 
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Fig. 2. Effect of incubation temperature onthe uptake of Fe(II) to the cytosol of reticulocytes (Retics) and erythrocytes (Mature). The figure shows (A) the 
results for uptake (means + S.E.M., n = 3) and (B) Arrhenius plots of the mean values. Incubation was performed in isotonic KCI (pH 7.0). 
locytes, and high concentrations of the reagents produced 
at least 95% inhibition. 
3.4. Kinetics of Fe(H) uptake 
The rate of iron uptake into the cytosolic fraction of 
reticulocytes increased as the incubation temperature was 
raised from 22°C to 37°C (Fig. 2A). However, with 
erythrocytes the rate reached a maximum at about 32°C 
and fell from this value as the temperature was raised to 
37°C. Arrhenius plots of these results were not linear, 
especially with erythrocytes (Fig. 2B) so that values of the 
activation energy (E a) could not be calculated for these 
cells. In the case of reticulocytes the plot was almost linear 
between 27°C and 37°C, and the approximate value for E a 
over this temperature range was calculated to be 74 kJ/mol. 
3.5. Effect of ATP depletion 
The method used to deplete ATP levels (incubation 
with iodoacetamide and inosine) has previously been shown 
to lower ATP concentrations of erythrocytes to less than 
20% of control values [12]. This was confirmed in the 
present work when the mean ATP concentration f reticu- 
locytes was lowered from the control value of 510 to 35 
nmol/ml cells. These changes were accompanied by 
marked inhibition of Fe(II) uptake (Fig. 3). That this effect 
is probably due to the lowering of the ATP levels, and not 
to a direct toxic effect of iodoacetamide, is indicated by 
the observation that iron uptake was not inhibited in cells 
to which the iodoacetamide was added immediately before 
the radioactive iron (Fig. 3). 
3.6. Effect of Na ÷ 
The findings that extracellular Na ÷ (Table 1) and 
amiloride [5,6] can inhibit Fe(II) uptake led to the sugges- 
tion that Na ÷ competes with Fe(II) for uptake by a 
Na÷/Fe 2+ exchange process [5]. This hypothesis was 
investigated by determining the effects of varying extracel- 
lular concentrations of NaC1 on iron uptake from KCI 
solutions containing increasing concentrations of Fe(II). It 
was found that NaC1 raised the K m for iron uptake but had 
little effect on the Vma x (Fig. 4), features which are charac- 
teristic of a competitive type of inhibition. 
3. 7. Uptake by rat and human erythrocytes 
The rates of transmembrane cation transport, including 
Mg 2÷ [14] have been shown to vary considerably between 
"~ 300- 
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Fig. 3. Effect of preincubation with iodoacetamide and inosine on Fe(II) 
transport into the cytosol of reticulocytes. The cells were incubated for 15 
min at 37°C in isotonic KC1 (pH 7.0) with varying concentrations of
Fe(II) after 30 min preincubation i the same solution containing no 
reagent ( • ), 5 mM iodoacetamide (A) or 5 mM iodoacetamide + 5 mM 
inosine (O). Also shown is the uptake by cells to which the iodoacet- 
amide was added at the same time as the radioactive iron (O). Similar 
results were obtained in a repeat experiment with reticulocytes and in two 
experiments with erythrocytes. 
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Fig. 4. Inhibition of Fe(lI) transport into reticulocytes by NaC1. The cells were incubated for 15 min at 37°C in isotonic solutions of KCI (pH 7.0) plus no 
NaCI (©), 2 mM NaCI ( I ) ,  4 mM NaCI (A) or 6 mM NaC1 (v) .  The figure shows Fe uptake to the cytosol (A) and Eadie-Hofstee plots of the uptake 
results (B). In this and a second experiment the addition of NaC1 had little effect on Vma x (nmol/ml cells) but raised the K m (~M)  values. Similar results 
were obtained with erythrocytes in two other experiments of this type. 
erythrocytes obtained from different animal species. In 
order to see whether this was the case for low-affinity 
Fetid transport and for comparison with Mg 2÷ transport, 
comparative studies were made between rat, human and 
rabbit erythrocytes. Iron uptake rates were found to be 
very low with human erythrocytes, high with rabbit cells, 
and intermediate with rat cells (Fig. 5). Also, with rat as 
well as rabbit cells, the rate of iron uptake increased as the 
KCI concentration was raised. 
3.8. Role of Mg 2 + in Fe(II) uptake 
Three types of experiment were undertaken to investi- 
gate the possible interrelations between Fe(II) and Mg 2÷ 
transport in erythroid cells: (1) measurement of Fe(II) 
uptake by cells with varying intracellular Mg 2+ concentra- 
tions, (2) determination of the effects of inhibitors on 
Mg2+-dependent Fe(II) uptake, and (3) investigation of 
whether or not inhibition of Fe(II) uptake by extracellular 
Mg 2÷ is competitive in nature. 
The effects of manipulation of the intracellular Mg e÷ 
concentration on Fe(II) uptake are illustrated in Fig. 6. 
With both erythrocytes and reticulocytes iron uptake in- 
creased markedly as the Mg :+ concentration was raised 
from 0 to 1.0 mM and was maintained at a high level as 
the concentration was raised further, to 12 mM with 
erythrocytes but to only 2 mM with reticulocytes ince 
hemolysis occurred with these cells at higher Mg 2÷ con- 
centrations. A feature of the results is the high level of 
uptake by erythrocytes which had been treated with 
A23187. This was a consistent but, as yet, unexplained 
observation. 
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Fig. 5. Iron transport into the cytosol of rabbit (0) ,  rat (•) and human (• )  erythrocytes. The cells were incubated at 37°C for 15 min with (A) varying 
concentrations of Fe(II), or (B) with 20 /xM Fe(II) in isotonic solutions containing varying concentrations of KC1. The latter solutions were prepared by 
mixing isotonic sucrose with isotonic KC1. The figure shows the result of one out of two separate xperiments which gave similar results. 
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Fig. 6. Effect of concentration of Mg 2+ on the uptake of Fe to the cytosol and stroma of erythrocytes and reticulocytes. The Mg 2+ concentrations were 
varied by the use of A23187, as described in the text. The values show the extracellular Mg 2÷ concentration during loading in the presence of A23187. 
Each result is the mean + S.E.M. of 3 -4  measurements of Fe uptake during 15 min incubation at 37°C with 20 /zM Fe(II) in isotonic KCI (pH 7.0). 
Concentrations of Mg 2÷ in excess of 2 mM produced hemolysis with reticulocytes, but not with erythrocytes. 
Several inhibitors of Fe(II) uptake by untreated cells 
were tested for their capacity to block Mg2+-dependent 
iron uptake using Mg2+-depleted cells and cells in which 
the intracellular Mg 2÷ concentration had been adjusted to 
1 mM by the A23187 exchange technique. They were all 
effective inhibitors of iron uptake by cells containing 1 
mM Mg 2÷ but, with the exception of quercetin, had little 
effect on iron uptake by MgE+-depleted cells (Fig. 7). 
Inhibitory extracellular concentrations of Mg2+ were 
found to increase the K m values but to have little effect on 
Vm~ x for iron uptake (Fig. 8). Hence, extracellular Mg 2÷ 
inhibits iron uptake in a competitive manner. 
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The iron transport mechanism investigated in this study 
is present in erythrocytes as well as reticulocytes and in 
both types of cells has a K m of approx. 15 /zM. Ferrous 
iron is transported preferentially to ferric iron. The process 
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Fig. 7. Effect of several inhibitors on iron transport to the cytosol of erythrocytes and reticulocytes in which the Mg z+ concentrations were adjusted by the 
use of A23187. The Mg 2+ concentrations shown on the figure (0 and 1 raM) are the extracellular Mg 2÷ concentrations which were present during 
treatment with A23187. Incubation with 20/zM Fe(II) was performed for 15 min at 37°C in isotonic KC1 (pH 7.0). The values are the means + S.E.M. of 
3 determinations with erythrocytes and the means of 2 determinations with reticulocytes. 
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Fig. 8. Inhibition of iron uptake by MgC12 . Reticulocytes were incubated with 20/zM Fe(II) at 37°C for 15 min in isotonic KCI (pH 7.0) containing zero 
(O), 35 /zM (11), 70 /xM (A) or 105 /zM (0)  MgCI 2. The figure shows uptake to the cytosol (A) and Eadie-Hofstee plots of the uptake results (B). In 
this and two other similar experiments he addition of MgCI 2 produced little change in lima x but caused a concentration-dependent increase in K m (/xM) 
values. 
has a high activation energy and appears to be dependent 
on cellular metabolism. Overall, the evidence points to a 
carrier-mediated process, possibly to an active transport 
process. 
The inhibitory effects of the other cations and of trans- 
port inhibitors provide clues to the nature of the process. In 
most instances at least 95% inhibition could be achieved 
by the use of the cations and inhibitors. This implies that 
only one Fe(II) transport process is involved or, if there is 
more than one, they have very similar properties with 
respect o the effects of the inhibitors. Inhibition by NaCI 
and amiloride indicates an involvement of Na ÷ transport 
as has been suggested earlier [5]. The competitive nature of 
the Na+-dependent i hibition makes it likely that Fe 2÷ and 
Na ÷ compete for a common site on the transport mecha- 
nism. However, other ions in addition to Fe 2÷ and Na ÷ 
may be involved. A role for Mg 2÷ is suggested by the 
greater sensitivity of Fe(II) transport o Mg 2÷ than to 
Ca 2÷. The high degree of sensitivity to Co 2÷, Ni 2÷ and 
Zn 2÷ and, to a lesser degree, to Mn 2+ and Cd 2÷ are also 
of interest. How these ions interact with Fe(II) transport 
will be the subject of future investigations. At present it 
should be noted that the IC50 values for the first 3 of these 
ions are the same as the Fe(II) concentration which was 
present in the incubation solutions (20 /zM). 
All of the biochemical reagents which inhibited Fe(II) 
uptake have been shown to inhibit other ion transport 
processes and, in many cases, to be inhibitors of ion-trans- 
porting ATPases. However, none of them are specific in 
their action so that it is not possible to conclude with any 
confidence that Fe(II) is transported by the action of an 
ATPase, although the possibility must be considered. In 
any case it is possible to rule out P- and F-type ion motive 
ATPases, since Fe(II) transport was resistant o vanadate 
and ouabain which inhibit P-type ATPases, and F-type 
ATPases are not present in erythrocytes since they have no 
mitochondria. 
Several investigators have shown that chicken, human, 
rat and ferret erythrocytes contain a Na+-dependent Mg 2÷ 
efflux mechanism which is considered to be due to the 
presence of a Na+/Mg 2+ antiport [13-22]. The Fe(II) 
transport process studied in this investigation is inhibited 
by both extracellular Na ÷ and Mg 2÷ and has many char- 
acteristics which are very similar to those of the Na+/Mg + 
exchanger. These include inhibition by amiloride, quini- 
dine, imipramine, Mn 2 ÷ and Co2÷; resistance to inhibition 
by vanadate, ouabain, bumetanide, furosemide and p-chlo- 
romercuriphenyl-sulfonic acid; and dependence on cellular 
ATP levels. Moreover, Na+/Mg 2+ exchange is more 
active in rat than human erythrocytes [18], as was found 
for Fe(II) uptake. Also, Na ÷ acts as a competitive inhibitor 
of Fe(II) uptake. Hence, there is good reason to suggest 
that Fe(II) is taken into erythroid cells by the Na+/Mg 2÷ 
exchanger, competing with extracellular Na ÷ for a place 
on the transporter. A role for Mg 2÷ efflux in Fe(II) uptake 
is also strongly supported by the stimulatory effects of 
intracellular Mg 2÷ on iron uptake and the inhibition of 
Mg2+-stimulated iron uptake by inhibitors of Na+/Mg 2÷ 
exchange. In addition, Mg 2÷ was found to inhibit Fe(II) 
uptake in a competitive manner which suggests that the 
exchanger can function in the reverse direction, taking 
Mg 2 + into the cells, as has been shown to be the case with 
Na+/Mg 2÷ exchange under appropriate conditions [22,23]. 
The arguments ummarized above are very strong evi- 
dence that low-affinity iron transport into erythroid cells is 
a newly-recognized manifestation of the function of a 
Na+/Mg 2÷ antiport. The present results also illustrate 
several new and interesting features of this transporter. 
These include higher levels of activity in rabbit than in rat 
or human cells, higher activity in immature rythroid cells 
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(reticulocytes) than in mature erythrocytes, and very high 
sensitivity to inhibition by diethylstilbestrol, valinomycin 
and certain divalent cations (Co 2÷, Ni 2+, Zn2÷). In the 
case of valinomycin we have evidence, to be reported 
elsewhere, that the inhibition is due to a competitive 
interaction between the valinomycin-K ÷ complex and the 
transporter, and is not due to alterations in transmembrane 
flux of K ÷ or potential difference. The results with Co 2÷, 
Ni 2+ and Zn 2+ raise the question that these metals can 
also be carried into erythroid cells by the Na+/Mg 2÷ 
transporter but, at present, there is no information on this 
matter. 
A possible explanation for the effect of changes in 
intracellular Mg 2+ concentration on iron uptake is that it 
results from changes in the concentration of ATP-Mg 2+ 
which is the substrate for an ATP-ase involved in iron 
transport. Indeed, there is evidence that Mg 2+ extrusion 
from human red cells by the Na+/Mg 2÷ antiport requires 
an input of metabolic energy from ATP hydrolysis [17]. 
The present results with ATP-depleted cells suggest hat 
the same applies to iron uptake. This conclusion is addi- 
tional to and not opposed to the one reached above that 
low affinity iron transport occurs via the Na÷/Mg 2+ 
antiport. 
An important question relates to the function of the 
low-affinity iron transport process. It is unlikely that this is 
the mechanism involved in iron uptake by cells in vivo 
since the uptake is inhibited by Na ÷, the major cation of 
the extracellular fluid. The function of Na+/Mg 2÷ an- 
tiport is believed to be that of mediating Mg 2÷ efflux from 
the cells to maintain the optimum intracellular concentra- 
tion of Mg 2+. Could it also function to export Fe z÷ ? Iron 
export is not an important function of erythroid cells, but it 
is important in other types of cells, particularly intestinal 
mucosal cells, placental trophoblast cells, macrophages 
and hepatocytes. Is iron efflux from the cells mediated by 
the same transport mechanism as described for erythroid 
cells in the present investigation, but working in the re- 
verse direction? There is evidence that Mg 2+ transport can 
reverse direction [22,23]. Why not Fe2+? Also, Na÷-de - 
pendent Mg 2÷ efflux has been described in several other 
types of cells in addition to erythroid cells [24]. Hence the 
possibility that iron efflux from the cells mentioned above 
may be mediated by the same or a related transporter must 
be considered and should be investigated in the future. At 
the present ime there is extremely little information on the 
mechanism by which iron is transported out of any type of 
cell. 
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